BIO-TECHNE Corp Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations
BIO-TECHNE Corp (TECH) reported Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations of $4.00 thousand for the 12-month period ending 2013-06-30, per its 10-K filed 2013-08-29.
Discontinued › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations · last filed 2013-08-29
- BIO-TECHNE Corp unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2013 was $4.00K, a 42.86% decline from fiscal 2012.
- BIO-TECHNE Corp unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2012 was $7.00K, a 22.22% decline from fiscal 2011.
- BIO-TECHNE Corp unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2011 was $9.00K, a 10.00% decline from fiscal 2010.
- BIO-TECHNE Corp unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2010 was $10.00K.
| Period end | Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations 12 month |
|---|---|
| 2013-06-30 | $4.00K 10-K · filed 2013-08-29 |
| 2012-06-30 | $7.00K 10-K · filed 2013-08-29 |
| 2011-06-30 | $9.00K 10-K · filed 2012-08-29 |
| 2010-06-30 | $10.00K 10-K · filed 2011-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |